PYX Resources: Achieving volume and diversification milestones. Watch the video here.
I for one have reported the insider trading and market abuse directly to The FCA.
This is AIM but expected better from ODX considering tie ups with U.K. Gov. Design Freeze can’t be let out or leaked but placing can.....
Tara Moore for CIGA healthcare part of the UK RTC
https://twitter.com/tara_moore7/status/1272593385522692097?s=21
Same question, but to anyone that uses Lloyd’s?
Thanks
Long term investor here, but if someone could help answer the following.
With all the brilliant news of late and postive RNS’s with ASCO why do MM’s continue to keep a lid on rally’s and suppress the price to breach new levels? Quilter must be out, warrants exercised?
There are currently three potential multi-billion dollar market products being worked on, with one having proven to be 40-50% more accurate than the market leader and soon to be demerged and sold on.
Happy to wait and sit on for a few years. But found it interesting other bio-tech firms get a whiff of news and jump 20%, whilst we are here sitting on a new stack of news with more incoming.
Long term investor here, but if someone could help answer the following.
With all the brilliant news of late and postive RNS’s with ASCO why do MM’s continue to keep a lid on rally’s and suppress the price to breach new levels? Quilter must be out, warrants exercised?
There are currently three potential multi-billion dollar market products being worked on, with one having proven to be 40-50% more accurate than the market leader and soon to be demerged and sold on.
Happy to wait and sit on for a few years. But found it interesting other bio-tech firms get a whiff of news and jump 20%, whilst we are here sitting on a new stack of news with more incoming.
Agreed, S&P clearly seem to be filling up their time marking companies as junk.
Just recently they downgraded both Renault and Ford to junk status.
Not been on here long.
FTSE up this morning as were banks up a few %, why the downward change?
Thanks all,
It’s Laboratory based and not POC
“ Abbott's SARS-CoV-2 IgG test identifies the IgG antibody, which is a protein that the body produces in the late stages of infection and may remain for up to months and possibly years after a person has recovered. Abbott's IgG antibody test will initially be available on its ARCHITECT® i1000SR and i2000SR laboratory instruments*. More than 2,000 of these instruments are in use in U.S. laboratories. These instruments can run up to 100-200 tests per hour.”
Topped up twice in the last hour
Just got this from Lloyds
"I have spoke to one of the members of the team that would handle this type of thing and we can't take part as it is too short of a deadline. "
As per the RNS today:
Within the next three months, the Company expects to be able to announce the CE Marking of its Genedrive® 96-SARS-CoV-2 test followed by FDA Emergency Use authorisation and its launch and first sales. Announcements of commercial agreements and revenue from the Genedrive® 96-SARS-CoV-2 test are also anticipated.
Later in the year, genedrive expects to announce a long-term contract agreement with the DoD and subsequent ordering under the contract. The completion of AIHL trials at Manchester and Liverpool NHS hospitals is expected, subject to the lifting of COVID-19 restrictions, following which the Company will launch the product in the UK and announce first sales.
The receipt of regulatory approvals and launch of the Genedrive® SARS-CoV-2 ID Kit are expected at the end of the year on the basis of emergency shortened timescales and subject to the risk factors outlined in "COVID-19 Market Risk" below.